News & Updates

Faecal microbiota transplant offers no relief for IBS
Faecal microbiota transplant offers no relief for IBS
26 Sep 2022 byTristan Manalac

Patients with irritable bowel syndrome (IBS) derive no clear benefit from faecal microbiota transplant (FMT), according to a recent study.

Faecal microbiota transplant offers no relief for IBS
26 Sep 2022
Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
Sotrovimab of no help in attenuating COVID-19 severity in face of Omicron BA.2 subvariant
26 Sep 2022
Mirabegron benefits men with OAB, erectile dysfunction
Mirabegron benefits men with OAB, erectile dysfunction
26 Sep 2022
Elobixibat affords metabolic benefits in type 2 diabetes
Elobixibat affords metabolic benefits in type 2 diabetes
25 Sep 2022

In type 2 diabetes (T2D) patients with constipation, treatment with elobixibat alleviates constipation while improving glucose metabolism and lowering serum low-density lipoprotein cholesterol (LDL-C) and arachidonic acid (AA) levels, according to the results of a single-arm pilot study.

Elobixibat affords metabolic benefits in type 2 diabetes
25 Sep 2022